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Measured as elapsed time from first use to dependence syndrome onset, the 
estimated ‘induction interval’ for cocaine is thought to be short relative to the 
cannabis interval, but little is known about risk of becoming dependent during first 
months after onset of use. Virtually all published estimates for this facet of drug 
dependence epidemiology are from life histories elicited years after first use. To 
improve estimation, we turn to new month-wise data from nationally representative 
samples of newly incident drug users identified via probability sampling and 
confidential computer-assisted self-interviews for the United States National Surveys 
on Drug Use and Health, 2004-2013. Standardized modules assessed first and most 
recent use, and dependence syndromes, for each drug subtype. A four-parameter Hill 
function depicts the drug dependence transition for subgroups defined by units of 
elapsed time from first to most recent use, with an expectation of greater cocaine 
dependence transitions for cocaine versus cannabis. This study’s novel estimates for 
cocaine users one month after first use show 2%-4% with cocaine dependence; 12%-
17% are dependent when use has persisted. Corresponding cannabis estimates are 0%-
1% after 1 month, but 10%-23% when use persists. Duration or persistence of cannabis 
smoking beyond an initial interval of a few months of use seems to be a signal of 
noteworthy risk for, or co-occurrence of, rapid-onset cannabis dependence, not too 
distant from cocaine estimates, when we sort newly incident users into subgroups 
defined by elapsed time from first to most recent use.
Key words: cocaine dependence; cannabis dependence; Hill function
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Introduction
In recent epidemiological research with United States (US) samples, a novel functional
analysis approach disclosed estimated transition probabilities for cocaine and for 
other drugs, with focus upon estimating risk of becoming a case of cocaine 
dependence within 12 months after onset of cocaine use, and with frequency of use 
as an underlying explanatory variable of central interest (Vsevolozhskaya and Anthony,
2015). In this research project, the aim is to extend the functional analysis approach 
for study of rapid transitions into cocaine dependence, which might depend upon or 
be interdependent with duration of use, with cannabis as a comparator agent in this 
inquiry. In addition, we hope to introduce the IJMPR audience to the four parameter 
Hill equation functional analysis approach we are using for estimation of drug-specific
transition probabilities, and to encourage a more general application of functional 
analysis in drug dependence research as well as neuropsychiatry studies.
By way of background, before 1985, outside of the coca-growing source countries, the
US, and Canada, few epidemiologists showed interest in cocaine. Thereafter, once its 
use had spread to western Europe, cocaine provoked concern previously reserved for 
other internationally regulated drugs such as heroin, the amphetamines, and cannabis
(United Nations, 2015). As such, this project’s functional analysis approach might be 
interesting for international audiences, especially when one seeks to compare 
cocaine-related harms with cannabis-related harms in cross-national studies. The 
functional analysis approach also should be of interest to psychiatric researchers in 
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general because it can be applied elsewhere, as illustrated with three mood and 
anxiety disorder examples for which estimated functional analysis parameters would 
be useful in future research and clinical practice – namely, the estimated effect of 
time elapsed (1) from onset of adolescent anhedonia until the first episode of Major 
Depression (MD), (2) from MD onset until the first post-MD suicide attempt, (3) from 
panic attack onset until newly incident agoraphobia. 
With respect to current empirical estimates of transition probabilities for cocaine 
dependence once cocaine use starts, there is general consistency across published 
studies based on various data sources, different years of study, and the year-wise 
retrospective measurement approach. Transition probability or risk estimates from 
these studies indicate that within 24 months after starting cocaine use, an estimated 
5%-6% of users have developed cocaine dependence. Corresponding estimates for 
cannabis transition probabilities are generally lower, at ~3% (Chen et al., 2005; Hasin 
et al., 2015; Lopez-Quintero et al., 2011; O'Brien and Anthony, 2005; Wagner and 
Anthony, 2007) However, a recent Australian sample of twins provides evidence of the 
predictive and explanatory value of elapsed time from first to second occasion of 
cannabis use, with short elapsed time predicting much larger cumulative incidence of 
cannabis use disorder (DSM “abuse” and/or dependence) than the generally observed 
three percent value for cannabis dependence (Hines et al., 2015). In the Australia 
study, the twins had to think back assessment over relatively long spans of time since 
onset of cannabis use; in the present study, all temporal and diagnostic assessments 
have been completed within an interval of 12 months since first cannabis use.
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We took these published values from year-wise studies as a point of departure. Our 
hypothesis was that the drug-specific transition probability estimates might vary 
considerably if one were to take into account the elapsed time from the very first use
of the drug until the most recent use of the drug, evaluated month-by-month since 
the start of the drug use, and with a restriction to newly incident users so that the 
recall and reporting interval is constrained to be quite short (i.e., no more than 12 
months duration).
We forecast potential observed interdependencies linking drug use duration with drug 
dependence processes, as well as some heterogeneity within duration-stratified newly
incident users. To illustrate, the first and most recent drug exposure can occur on the 
same day, as sometimes is true for drug users when initial cocaine or cannabis 
experiences are aversive or punishing from a behavioral analysis standpoint (e.g., 
when the drug experience serves to trigger an unexpected acute anxiety reaction). 
For these users, their first drug use might well be their last drug use. With such short 
drug use duration, a drug dependence process does not get started. Repetition of 
drug-taking occasions is required before a dependence syndrome can emerge. 
For some users, the first cocaine or cannabis experiences seem to be exceptionally 
reinforcing. Drug exposure might rapidly become a daily occurrence, sustained for 
many months. Here, elapsed time from first to most recent use might be short or can 
be quite lengthy, with observed dates of most recent use many months after first use.
In addition, there can be feedback loops. Once drug dependence processes start, 
these same processes can become explanations for subsequently extended durations 
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of use, over and above any reinforcing function that drug use might have served when
it was first initiated (Anthony, 2010).
As a manifestation of heterogeneity, among the newly incident users with very short 
elapsed time, the single-occasion users are grouped with users whose month of first 
use and month of survey assessment are one and the same, some of whom might have
had a highly reinforcing first use but have not yet had time to accumulate more than 
one month of experience with the drug. Among newly incident users with multiple 
months of elapsed time from first use until most recent use, there are some who have
become sustained daily users, as well as others who have used on no more than a few 
occasions, separated by long intervals of no use whatsoever.
The line of thinking for this study required a methodological extension of the initial 
Vsevolozhskaya-Anthony application of functional analysis in epidemiological research 
on estimated probability of a clinical outcome such as drug dependence, for which 
‘frequency of drug use’ was specified as an interdependent covariate. In this 
extension, we have replaced the ‘frequency of drug use’ construct with the dimension
of elapsed time from first to most recent drug exposure (i.e., observed ‘duration’ of 
use).
In ‘functional analysis’ we draw upon non-linear regression models based on the Hill 
equation, which has somewhat more complexity than logistic regression models as 
generally applied in neuropsychiatric research to date. In binary response logistic 
regression, the slope parameters are the ‘estimands’ of interest (e.g., (Jacobi et al., 
2015; Ringeisen et al., 2015)), but there are four parameters of interest when Hill 
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equation models are fit to observed data. These four parameters can be used to link 
an explanatory variable of interest with probability of a binary response. In this 
study’s ‘month-wise’ context, we specify elapsed time from first to most recent drug 
as an interdependent covariate of interest, with the estimated probability of drug 
dependence as response, constraining the analysis to newly incident users who have 
had no more than 12 months since the month of first starting their drug use 
experiences. Here, the concept of ‘interdependence’ is one that allows for feedback 
loops such that a dependence process can drive up duration of use. Multi-wave 
longitudinal research with month-by-month assessments of newly incident users can 
build from this study’s cross-sectional estimates in order to characterize these 
acknowledged feedback loops (Anthony, 2010).
Two other salient methodological issues surface in the context of our model. First, 
cannabis dependence and cocaine dependence are measured as separable outcomes 
for which there is no question about whether the agent is the cause of the outcome 
(i.e., the cause-effect association is not at issue; the agent qualifies as a necessary 
but not sufficient causal influence). A newly incident cannabis user cannot develop 
cocaine dependence until cocaine exposure occurs. A newly incident cocaine user 
cannot develop cannabis dependence until cannabis exposure occurs. Analogies to 
communicable disease research are pertinent. Cholera vibrio exposure per se does not
cause tuberculosis; it has been designated as the necessary cause for cholera as a 
clinical outcome. Tubercle bacillus exposure per se does not cause cholera; it has 
been designated as the necessary cause for tuberculosis as a clinical outcome. As 
such, we estimate comparative Hill function parameters for cocaine versus cannabis 
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as one might estimate these parameters for cholera vibrio and tuberculosis (as in 
probability of transitioning from first effective agent exposure to onset of clinically 
apparent disease within 12 months after effective contact). Possibilities of subgroup 
variation in transition probabilities are pertinent here (e.g., males might be more 
likely to transition than females). Nonetheless, when the agent is designated as a 
necessary cause for the clinical outcome, there is no issue comparable to 
‘confounding’ as might surface when hypotheses about possibly confounded suspected
causes are being evaluated in chronic disease epidemiology research.
Second, some readers might critique the cross-sectional nature of the observed data 
or ask for high dimensional propensity scoring or other nuanced refinements as might 
be used to estimate the functional analysis parameters with adjustments for macro-
level differences (e.g., local area drug availability) or for individual-level differences 
(e.g., prior use of other drugs, genetic susceptibility traits). We agree that these 
refinements might be useful, but this study’s initial functional analysis estimates 
provide a foundation upon which future prospectively conducted research might be 
built, with design-based or analysis-based experimental control over important 
macro- and micro-level covariates. In this respect, the work is analogous to derivation
of starting estimates based on cross-sectional data in order to lay plans for sample 
size requirements, optimal between-assessment intervals, and other facets of 
subsequent prospective and longitudinal research projects.
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Methods
Study population, sampling, and assessment procedures
The study population consists of non-institutionalized civilian United States 
community residents in each of the 50 states and the District of Columbia, age 12 
years and older, as specified each year for the 2004-2013 National Surveys on Drug Use
and Health (NSDUH). Each year’s survey sample was drawn as an independent 
multistage area probability sample of this study population, with annual targeted 
sample size of ~67,500 individuals. NSDUH participants completed a multi-module 
audio-enhanced computer assisted self-interview (ACASI). The ACASI assessment 
included standardized multi-item DSM-IV drug dependence syndrome diagnostic 
modules akin to those used in the Diagnostic Interview Schedule, the Composite 
International Diagnostic Interview, and the Alcohol Use Disorders and Associated 
Disabilities Interview Schedules (American Psychiatric Association, 2000). These case 
ascertainment modules were used to identify newly incident drug dependence cases 
among the newly incident drug users. (DSM-5 was not yet published when the NSDUH 
2004-2013 assessments were completed.) The study protocols were reviewed and 
approved by cognizant institutional review boards. NSDUH details and methods 
descriptions are widely available in prior articles and in numerous online reports
(Parker and Anthony, 2014; Seedall and Anthony, 2013; United States. The Office of 
Applied Studies, 2014; Vsevolozhskaya and Anthony, 2014) 
To protect respondents’ confidentiality, for each survey year, public use data files are 
created based on observations for ~55,000 respondents.  We fit parametric non-linear 
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Hill models to weighted observations from the NSDUH ‘SDA’ datasets (United States. 
Substance Abuse and Mental Health Data Archive, 2014).
Whereas each NSDUH is conducted as a cross-sectional survey with an independently 
drawn replication sample, its month-by-month data on the first occasion of drug use 
make it possible to focus on the set of ‘newly incident drug users.’ This set 
encompasses users for whom no more than 12 months passed between the month of 
first use (MFU) and the effective assessment date. In some instances month of 
assessment was not recorded, but the user reported the month of the most recent or 
‘last’ use (MLU). For a relatively small subset, only ‘calendar quarter of last use’ is 
known, and the MLU value has been logically assigned to the middle month of the 
assessment quarter. For instance, when these newly incident users were assessed in 
the 1st quarter of 2012, the MLU was logically assigned to the quarter midpoint, or 
February 15th of 2012. After this logical imputation, the resulting sample sizes were n
= 3,186 for newly incident cocaine users and n = 11,629 for newly incident cannabis 
users (all observed within 12 months since onset of use). Supplementary Table S1 
provides additional sample characteristics.
Functional data analysis 
The R statistical software “survey” analysis routines (Lumley, 2004) were used to 
account for the NSDUH complex survey design and to estimate weighted empirical 
probabilities of dependence, as well as their corresponding variances. When attention
is paid to sampling units and clustering weights, tabulated values of the empirical 
probabilities of drug dependence by the ‘duration’ of drug use in months can be 
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estimated, where ‘duration’ is estimated as elapsed time from first month of starting 
drug use until most recent month of using the drug. Standard errors of the empirical 
point estimates can be approximated via Taylor series linearization (Heeringa et al., 
2010).  Non-linear interpolation to empirical probabilities of dependence is achieved 
via a parametric Hill equation as:
y i=(Pmax−Pmin )×
1
1+( P D50x i )
k +Pmin+ϵ i ,
 
where y i   is the empirical probability of drug dependence and xi  is the exposure
duration in months (i.e., xi=MLU i−MFU i ) for subject i , i=1,…,n . The ϵ i ’s 
are assumed to be independent and normally distributed with constant variance σ2
. The Pmin , Pmax , PD50  and k  are Hill function parameters requiring 
estimation. An iterative estimation process requires users to supply plausible starting 
parameter values, supplied here as “eye-balled” empirical point estimates. 
Alternative approaches are described elsewhere (Ritz and Streibig, 2008).
The four parameters that control the particular shape of the sigmoid Hill function 
have the following epidemiological interpretation in the context of current research: 
(1) Pmin  is the estimated probability of drug dependence among the exposed for 
whom there are no more than a few repetitions of use within the first few months 
after onset, including those for whom initial experience might have been aversive or 
perhaps relatively non-reinforcing, or for whom agent availability might be quite 
constrained; (2) Pmax  is the probability of drug dependence among the exposed who
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seek out or otherwise have agent availability, as manifest in greater elapsed time 
from first to most recent drug use within the 12 months after initial exposure; (3)
PD50  stands for the number of months of exposure after which the probability of 
drug dependence is halfway to Pmax  (within the first 12 months after onset of drug 
use); and finally (4) k  is the rate of transition from Pmin  to  Pmax  , evaluated 
at month PD50 . In some contexts, this study’s estimate of PD50× 2  , based on 
the month-wise data, will serve as a useful starting value for elapsed time until the 
peak risk of becoming a clinically apparent case has been reached, as an 
approximation of a maximum for each agent’s induction interval after initial 
exposure.
Results 
Based on functional analysis of data on newly incident users characterized in Table S1,
Figure 1 shows estimated probability of observed cocaine dependence among newly 
incident cocaine users across a span of 12 months since cocaine use onset. Figure 2 is 
focused on the experiences of newly incident cannabis users, and depicts 
corresponding cannabis dependence risk estimates, each plotted in relation to the 
elapsed time from first to last occasion of use. Solid dots show empirical point 
estimates for the drug dependence proportions plotted for subgroups defined by 
elapsed time from MFU to MLU, with the origin anchored at 0.5 months when 
MFU=MLU such that maximum x = 12.5 ; vertical error bars depict 95% confidence 
intervals via logit transformations (Vsevolozhskaya and Anthony, 2014). Solid lines 
display non-linear Hill function estimates for transitions from first drug use to 
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dependence as might be governed by, or interdependent with, elapsed time from first
to most recent use, all observed within a fairly short interval after first use. 
In Figures 1 and 2, bands around solid lines characterize variability in estimates for 
non-linear Hill function parameters, derived from weighted residual bootstrap 
procedures (Vsevolozhskaya and Anthony, 2015). The weighted residual bootstrap 
procedure was used instead of Wald-type confidence intervals (e.g., plus minus twice 
standard error) due to substantive departures from the model assumptions. 
Specifically, in both Figures 1 and 2, vertical error bars are getting wider along the
x –axis, indicating violation of the constant variance assumption, which may result 
in biased and/or distorted standard errors. As such, we turned to the bootstrap 
approach, which does not rely on model assumptions.
Estimates from fitted Hill functions agree with a theoretically plausible specification 
that any rapid transition from first drug use to dependence among newly incident 
cannabis users should be smoother and slower than is observed for newly incident 
cocaine users, at least when elapsed time is relatively short. The tighter confidence 
bounds around the solid line for cannabis dependence are due to much larger numbers
of newly incident cannabis users in the NSDUH samples. 
Quantification of contrasting transitions to dependence for each of these two drugs is 
achieved in the comparison of the four governing parameters of estimated Hill 
functions. Table 1 depicts their 95% confidence intervals (CI) from the weighted 
bootstrap procedure.
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[Table 1 about here]
The Hill function estimates in Table 1 for cocaine suggest that roughly 2% of cocaine 
users are becoming cocaine dependent within about two months of elapsed time from
1st until most recent cocaine use ( Pmin  95% CI: 2%, 4%), after which risk shifts 
upward (slope, k  = 6.6 at PD50  = 3 months) toward Pmax  of 14% (95% CI: 
12%,17%). The maximum is observed as early as an estimated ‘induction interval’ of 6 
months ( PD50× 2 ) of cocaine use.
For cannabis, Table 1 estimates show that relatively few are becoming cannabis 
dependent within first two months after first exposure. Relative to cocaine, there is a
much more gradual upward shift in risk of dependence (estimated slope is k  = 2.2 
at PD50  = 5 months). Based on observations within 12 months after onset of 
cannabis use, estimated Pmax = 13% (95% CI: 10%, 23%). That is, roughly one in 7-8 
newly incident users are becoming cannabis dependent when elapsed time from first 
to most recent cannabis use extends past 10 months ( PD50× 2 ).
To contrast our findings with estimates from a more familiar logistic regression (LR), 
we fit the LR model for a binary Y j=0,1  drug dependence response, with the 
exposure duration as covariate, and with Hill function estimation routing retained to 
account for the NSDUH complex survey design. Resulting odds ratio estimates were 
1.3 for cannabis (95% CI: 1.03, 1.6) and 1.2 for cocaine (95% CI: 1.2, 1.3). Fitted 
values from these models are shown in Figures 1 and 2 as dotted blue lines.
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Discussion
Evaluated in relation to the few prior projects with large epidemiological community 
samples of newly incident or lifetime drug users, this study is the first one to 
substitute a month-wise approach in place of a year-wise approach for study of drug 
dependence processes emerging when no more than a few months have passed from 
the start of drug use until the most recent drug use. In contrast, all prior 
epidemiological studies of MLU-MFU differences among newly incident users have 
looked across the 1 or 2 years after drug use has started, facing larger constraints. 
Why? Because elapsed time almost always has been conceptualized with a time-scale 
of years, not months. The time-scale in years typically has been derived by taking 
differences between respondents’ age on an assessment date versus age of first drug 
use (Lopez-Quintero et al., 2011; O'Brien and Anthony, 2005; Wagner and Anthony, 
2002). Here, with a focus on newly incident users assessed no more than 12 months 
after first use, the month-wise time scale is based on standardized responses to 
questions about the first month of use and the most recent month of use, as of the 
date of survey assessment.
This study’s month-wise approach to the elapsed time dimension, with estimation of 
Hill function Pmin  and Pmax  values, yields a noteworthy and somewhat 
unexpected discovery. Namely, cocaine’s Pmin  estimate is robustly larger than the
Pmin  estimate for cannabis, but the Pmax  estimates do not differ statistically. An 
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inference from Pmin  is that the newly incident cocaine users are more likely to have
become cocaine dependent during their first months after onset of use and with 
relatively short elapsed time from first use to most recent use, as compared to risk of 
cannabis dependence during the first months of cannabis use. The inference from
Pmax  is one of no corresponding cocaine-cannabis difference when elapsed time 
from first to most recent use has a value of about 10 months or larger.
Our introduction mentions the possibility of feedback loops such that an incipient 
drug dependence process might help determine duration or persistence of drug use 
(i.e., greater elapsed time from first to most recent use), with the feedback 
becoming more salient once a clinically recognizable drug dependence syndrome has 
formed (Anthony, 2010). In this respect, the Pmin  comparison is noteworthy because
it is during the Pmin  interval of elapsed time (i.e., 0-2 months after first drug use) 
that feedback might be least salient when fewer users will have developed 
dependence. Given the observed cocaine-cannabis differences in Pmin , within 0-2 
months after first use, future research projects might focus on the first three months 
of drug experience, after which the slope, k , for cocaine rises more sharply than is
seen in the slope for cannabis. 
While we appreciate that the Hill function point estimates for cocaine’s  PD50  and
k   parameters are numerically larger than the corresponding cannabis estimates, in
this instance the bootstrapped confidence intervals show at least modest overlap. 
This was not the case for Pmin .
16
Another discovery of interest is that the Pmax  parameter estimates for cocaine and 
cannabis are not appreciably different from one another (i.e., when the elapsed time 
dimension has a value greater than about 10 months). Notably, the observed Pmax  
equivalencies serve as an indication of generally comparable cocaine and cannabis 
dependence transition probabilities for the subgroup of newly incident users observed
with more than about 10 months from first to most recent use. We remind our readers
about heterogeneity of the duration-stratified subgroups, as mentioned in our 
introduction.  The long duration subgroups include individuals who have become 
persistent daily users and for whom cessation of use has not yet materialized (within 
the first 12 months after first use). It also includes individuals who might be described
as ‘chippers’ who consistently use every weekend since first use, but do not use 
during the work week. Even with this heterogeneity, the Hill function Pmax  
parameter estimates and the fitted values from logistic regression models indicate a 
duration-associated increased odds of seeing a drug dependence syndrome emerge 
within 12 months after initial drug-taking for the subgroup of newly incident users 
with larger elapsed time values, irrespective of whether they have been using 
cannabis or cocaine. The degree to which the observed equivalence of cocaine and 
cannabis can be traced back to relative affordability or availability of these drug 
compounds cannot be evaluated with the data in hand. It is certain that other 
theoretically important influences also might be at play (e.g., greater clinically 
significant toxicity for sustained cocaine users relative to sustained cannabis users).
Before any additional discussion of these new findings, several study limitations 
deserve attention. First, self-report gives rise to potential ‘methods effects’ and a 
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common method variance bias (Podsakoff et al., 2003). Nonetheless, self-report 
assessment methods have been characterized as having both valid and reliable levels 
of validity in nationally representative samples (Del Boca and Darkes, 2003; Richman 
et al., 1999; Vignali et al., 2012).
We also note that longitudinal research commonly is regarded as a superior 
alternative to any cross-sectional approach. We cannot disagree with this perspective.
Nonetheless, we note that any meritorious proposal for longitudinal research includes 
a consideration of (a) sample size requirements, and (b) between-assessment design 
intervals, and these considerations can be guided by starting estimates from cross-
sectional research of the type derived here. We also note that cross-sectionally 
derived estimates of this type do not suffer from differential attrition faced in 
longitudinal studies that compare experiences of users of various drug compounds
(Anthony, 2010; Lopez-Quintero et al., 2015; Seedall and Anthony, 2015). 
Finally, our description of the functional analysis approach and specification of 
software for performing these analyses (available at 
http://www.epi.msu.edu/vsevoloz/scripts/Hill_function/) does not, at present, 
extend to the more complex problem of simultaneous adjustment for multiple 
possible confounding variables. We have planned additional functional analysis 
methods research that will make it possible to accommodate possibilities of 
confounding via covariate adjustments. For this reason, our introduction to the 
functional analysis approach does not include covariate-controls seen when the 
generalized linear model is used with a logistic link (e.g., Hines et al., 2015).
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Study limitations of this type motivate a cautious approach when these 
epidemiological estimates for cocaine and cannabis are interpreted. Some readers 
might wish to interpret the estimates as manifestations of ‘properties of the drug’ 
such as an ‘addiction potential’ or as a ‘dependence liability’ manifestation. In our 
view, this interpretation of epidemiological estimates is premature. The relatively 
uncontrolled community context of epidemiological research does not take into 
account macro-level environmental conditions such as local drug availability or micro-
level conditions such as individual susceptibility traits that might be pertinent to 
some drug exposures but not to others (Caulkins et al., 2015; Cerda et al., 2012; 
Hines et al., 2015).
Notwithstanding limitations of this type, we hope readers will appreciate this initial 
application of a functional analysis approach, with study of elapsed time from first 
use to most recent use as an important dimension generally not considered in prior 
studies. To illustrate, an American child psychiatrist seeing an adolescent patient with
untreated newly incident anhedonia of two weeks duration now can turn to published 
epidemiological estimates to learn that Major Depression in adulthood is a likely 
outcome, with approaching 50% probability (Wilcox and Anthony, 2004) . If the Hill 
function approach were applied to new data on duration of adolescent-onset 
anhedonia relative to adult-onset MD, analogously useful probability estimates could 
be derived for anhedonia of 1, 2, or 3 weeks, or longer duration. Similar applications 
to MD and suicide attempt, as well as panic attack and agoraphobia, can be worked 
out as future functional analysis applications. Post-traumatic stress disorder as a 
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response to specific types of qualifying traumatic events also can be studied using the
Hill equation functional analysis approach and the software we have shared.
Finally, one of our findings suggested greater equivalence between drug dependence 
odds for cocaine and cannabis users with 10-12 months separating first and most 
recent use. Commentary about the implications of these epidemiological estimates 
for drug policy decision-making now would be speculative and premature. 
Nonetheless, it does not escape our attention that cannabis dependence estimates at 
this level might have some importance in relation to judgments made by jurisdictions 
that are changing their cannabis policies toward increased availability and reduced 
‘cost’, which might be expected to increase duration of use among newly incident 
cannabis users. Nonetheless, little more than speculation is possible when trying to 
link this study's estimates to the recent cannabis policy debates. Under the best 
policy analysis circumstances, empirical risks of clinically important outcomes such as 
drug dependence must be evaluated relative to the clear harmfulness of criminal 
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Table 1: Comparative estimates of Hill function parameters characterizing probability
of developing drug dependence soon after first occurrence of newly incident drug use,
for two drugs: cocaine and cannabis. Data from the United States National Surveys on 
Drug Use and Health, 2004-2013.
                 Parameters (95% Bootstrap Confidence Intervals)
Pmin Pmax PD50 k
Cocainea 0.02 (0.02, 0.04) 0.14 (0.12, 0.17) 3 (2, 3) 6.60 (2.75, 1.69)
Cannabisb 0.00 (0.00, 0.01) 0.13 (0.10,0.23) 5 (3, 10) 2.20 (1.38, 3.50)
a Unweighted number of newly incident cocaine users, n = 3,186.
b Unweighted number of newly incident cannabis users, n = 11,629. 
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Figures
Figure 1. Estimated non-linear parametric function for occurrence of cocaine 
dependence soon after onset of cocaine use, plotted in relation to elapsed time from 
first to most recent use (n = 3,186 newly incident cocaine users). Data from the 
United States National Surveys on Drug Use and Health, 2004-2013. (The function 
describes the estimated relationships linking ‘duration’ of drug use among newly 
incident cocaine users and their estimated probability of becoming cocaine dependent
within 12 months after first cocaine use.)
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Figure 2. Estimated non-linear parametric function for occurrence of cannabis 
dependence soon after onset of cannabis use, plotted in relation to elapsed time from
first to most recent use (n = 11,629 newly incident cannabis users). Data from the 
United States National Surveys on Drug Use and Health, 2004-2013. (The function 
describes the estimated relationships linking ‘duration’ of drug use among newly 
incident cannabis users and their estimated probability of becoming cannabis 
dependent within 12 months after first cannabis use.)
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Supplementary Table
Table S1: Characteristics of the newly incident cannabis and cocaine users, National 
Surveys on Drug Use and Health, US, 2004-2013.  
Newly Incident Cannabis 
Users (n = 11,629)
Newly Incident Cocaine 
Users (n = 3,186)
Sex:
  Male 46.5% 51.6%
  Female 53.5% 48.4%
Age Group:
  12-17 62.9% 30.5%
  18-25 35.4% 65.8%
  26-34 1.1% 2.9%
  35 or Older 0.6% 0.8%
Other Drugs Used Before:
  Tobacco Cigarettes 63.9% 95.2%
  Alcoholic Beverages 90.6% 99.2%
  Cannabis --- 97.6%
  Cocaine 2.6% ---
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